Retatrutide
Triple-agonist (GLP-1 / GIP / glucagon)
Retatrutide is a 3 receptor agonist that simultaneously activates the glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and glucagon receptors. It is a synthetic peptide with a half life of 6 days, making it suitable for a single weekly subcutaneous injection. Some users prefer to split their weekly total into 2 separate shots administered every 3 days to maintain more consistent levels of appetite suppression throughout the week.
The specific inclusion of the glucagon component increases energy expenditure and lipolysis, which some recreational users report eliminates the crushing fatigue often caused by earlier generations of weight loss medications. This mechanism primes the body to utilize fat stores more effectively while allowing the user to maintain a high degree of physical energy and mental focus.
Standard dosing protocols typically begin at 1 mg or 2 mg per week to allow the gastrointestinal system to adapt to the metabolic changes. Depending on individual tolerance and results, users may titrate their dosage upward to 4 mg, 8 mg, or as high as 12 mg.
The compound enforces strict dietary discipline through a biological feedback loop; consuming fatty or processed foods while on the medication frequently triggers intense heartburn and burps that taste like a previous meal. This effectively forces an adherence to whole foods and high fiber to avoid gastrointestinal distress. Many users have observed that their blood markers, including lipid values and blood pressure, improve significantly while on the peptide.
A primary focus for those in the performance world is the preservation of lean body mass during the rapid fat loss facilitated by this compound. Because the suppression of food noise is so profound, it is easy to maintain a caloric deficit deep enough to risk muscle wasting.
Common side effects include dose dependent nausea, diarrhea, and a slight increase in resting heart rate, which is a characteristic effect of activating the glucagon receptor. As the body adapts to the titration, these acute side effects typically subside, leaving a potent tool for long term body composition management.